XV Konferencja Naukowa Polskiego Towarzystwa Hepatologicznego
News
Current issue
Archival Issues
Search
Newsletter
Manuscript Submission
 » 
Journal Abstract
 
Silymarin in treatment of liver diseases
Napoleon Waszkiewicz, Sławomir D. Szajda, Magdalena Waszkiewicz, Małgorzata Knaś, Małgorzata Borzym-Kluczyk, Jacek Dobryniewski, Ewa Dutkiewicz, Piotr Zwierz, Krzysztof Zwierz
Medical Science Review - Hepatologia 2006; 6 92-98
aaICID: 449256
Article type: Original article
IC™ Value: 3.59
Abstract provided by Publisher
 
Silymarin, the active component of milk thistle (Silybum marianum), is a mixture of the flavonoids silybin, silychristin, and silydianin. Silybin is the most prevalent of the three flavonoids and the most biologically active. Silymarin has multiple hepatoprotective mechanisms of action: antioxidant activity, anti-inflammatory effect, toxin blockade, protein synthesis, and antifibrotic activity. Silymarin was once used in the treatment of varicose veins, menstrual difficulty, and damage to the liver, spleen, and kidneys. It is currently prescribed as a therapeutic and hepatoprotective agent, especially in the treatment of toxin exposure, cirrhosis, and chronic hepatitis.


ICID 449256


Related articles
  • in IndexCopernicus™
         sylimaryna [1 related records]
         sylibina [1 related records]
         hepatotoksyczność [3 related records]
         hepatoprotekcja [1 related records]


  •  

    Copyright © Medical Science Review - Hepatologia  2017
    Page created by Index Copernicus Ltd. All Rights reserved.